142 related articles for article (PubMed ID: 35220228)
1. Risk of Second Primary Malignancies After External Beam Radiotherapy for Thyroid Cancer.
Jin MC; Qian ZJ; Megwalu UC
Anticancer Res; 2022 Mar; 42(3):1359-1365. PubMed ID: 35220228
[TBL] [Abstract][Full Text] [Related]
2. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis.
Moschini M; Zaffuto E; Karakiewicz PI; Andrea DD; Foerster B; Abufaraj M; Soria F; Mattei A; Montorsi F; Briganti A; Shariat SF
Eur Urol; 2019 Feb; 75(2):319-328. PubMed ID: 30293908
[TBL] [Abstract][Full Text] [Related]
3. Radiotherapy for primary thyroid cancer as a risk factor for second primary cancers.
Chuang SC; Hashibe M; Yu GP; Le AD; Cao W; Hurwitz EL; Rao JY; Neugut AI; Zhang ZF
Cancer Lett; 2006 Jul; 238(1):42-52. PubMed ID: 16039041
[TBL] [Abstract][Full Text] [Related]
4. Risk of mesothelioma following external beam radiotherapy for prostate cancer: a cohort analysis of SEER database.
Farioli A; Violante FS; Mattioli S; Curti S; Kriebel D
Cancer Causes Control; 2013 Aug; 24(8):1535-45. PubMed ID: 23702885
[TBL] [Abstract][Full Text] [Related]
5. Radiation-induced mesothelioma among long-term solid cancer survivors: a longitudinal analysis of SEER database.
Farioli A; Ottone M; Morganti AG; Compagnone G; Romani F; Cammelli S; Mattioli S; Violante FS
Cancer Med; 2016 May; 5(5):950-9. PubMed ID: 26860323
[TBL] [Abstract][Full Text] [Related]
6. Radiation and Second Primary Thyroid Cancer Following Index Head and Neck Cancer.
Polednik KM; Simpson MC; Adjei Boakye E; Mohammed KA; J Dombrowski J; Varvares MA; Osazuwa-Peters N
Laryngoscope; 2019 Apr; 129(4):1014-1020. PubMed ID: 30208210
[TBL] [Abstract][Full Text] [Related]
7. Risk of subsequent primary cancers after carbon ion radiotherapy, photon radiotherapy, or surgery for localised prostate cancer: a propensity score-weighted, retrospective, cohort study.
Mohamad O; Tabuchi T; Nitta Y; Nomoto A; Sato A; Kasuya G; Makishima H; Choy H; Yamada S; Morishima T; Tsuji H; Miyashiro I; Kamada T
Lancet Oncol; 2019 May; 20(5):674-685. PubMed ID: 30885458
[TBL] [Abstract][Full Text] [Related]
8. The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies.
Krasnow RE; Rodríguez D; Nagle RT; Mossanen M; Kibel AS; Chang SL
Urol Oncol; 2018 Nov; 36(11):500.e11-500.e19. PubMed ID: 30249519
[TBL] [Abstract][Full Text] [Related]
9. Coupling of prostate and thyroid cancer diagnoses in the United States.
Tomaszewski JJ; Uzzo RG; Egleston B; Corcoran AT; Mehrazin R; Geynisman DM; Ridge JA; Veloski C; Kocher N; Smaldone MC; Kutikov A
Ann Surg Oncol; 2015 Mar; 22(3):1043-9. PubMed ID: 25205302
[TBL] [Abstract][Full Text] [Related]
10. Risk of second malignancies among survivors of pediatric thyroid cancer.
Adly MH; Sobhy M; Rezk MA; Ishak M; Afifi MA; Shafie AE; Ali MA; Zekri W; Alfaar AS; Rashed WM
Int J Clin Oncol; 2018 Aug; 23(4):625-633. PubMed ID: 29492793
[TBL] [Abstract][Full Text] [Related]
11. Risk and prognosis of secondary lung cancer after radiation therapy for thoracic malignancies.
Chen K; Liu C; Li X; Chen T; Liu S; Xiong F; Zhang Z
Clin Respir J; 2024 May; 18(5):e13760. PubMed ID: 38725324
[TBL] [Abstract][Full Text] [Related]
12. The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer.
Brown AP; Chen J; Hitchcock YJ; Szabo A; Shrieve DC; Tward JD
J Clin Endocrinol Metab; 2008 Feb; 93(2):504-15. PubMed ID: 18029468
[TBL] [Abstract][Full Text] [Related]
13. Risk of thyroid cancer after therapeutic irradiation in adult patients: An Age-Based surveillance, epidemiology, and end results analysis.
Dalwadi SM; Dorman C; Fisher SB; Bonnen M; Grubbs E; Ludwig MS
Laryngoscope; 2020 Aug; 130(8):2081-2086. PubMed ID: 31747075
[TBL] [Abstract][Full Text] [Related]
14. Incidence of second malignancies after external beam radiotherapy for clinical stage I testicular seminoma.
Lewinshtein D; Gulati R; Nelson PS; Porter CR
BJU Int; 2012 Mar; 109(5):706-12. PubMed ID: 21883828
[TBL] [Abstract][Full Text] [Related]
15. Comparison of second cancer risks from brachytherapy and external beam therapy after uterine corpus cancer.
Lönn S; Gilbert ES; Ron E; Smith SA; Stovall M; Curtis RE
Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):464-74. PubMed ID: 20142245
[TBL] [Abstract][Full Text] [Related]
16. Risk of second primary malignancies associated with radiotherapy in prostate cancer patients: competing risk analysis.
Wu Y; Li Y; Han C; Chong Y; Kang K; Liu Z; Zhang F
Future Oncol; 2022 Feb; 18(4):445-455. PubMed ID: 35018785
[TBL] [Abstract][Full Text] [Related]
17. Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy.
Iyer NG; Morris LG; Tuttle RM; Shaha AR; Ganly I
Cancer; 2011 Oct; 117(19):4439-46. PubMed ID: 21432843
[TBL] [Abstract][Full Text] [Related]
18. Incidence of second malignancies among patients treated with proton versus photon radiation.
Chung CS; Yock TI; Nelson K; Xu Y; Keating NL; Tarbell NJ
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):46-52. PubMed ID: 23778197
[TBL] [Abstract][Full Text] [Related]
19. Second primary cancer after radiotherapy for prostate cancer--a seer analysis of brachytherapy versus external beam radiotherapy.
Abdel-Wahab M; Reis IM; Hamilton K
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):58-68. PubMed ID: 18374503
[TBL] [Abstract][Full Text] [Related]
20. External Beam Radiotherapy for Medullary Thyroid Cancer Following Total or Near-Total Thyroidectomy.
Jin M; Megwalu UC; Noel JE
Otolaryngol Head Neck Surg; 2021 Jan; 164(1):97-103. PubMed ID: 32746731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]